Published in J Heart Lung Transplant on February 01, 1996
Lung transplantation for cystic fibrosis. Proc Am Thorac Soc (2009) 0.83
Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J (2009) 6.64
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. Eur Respir J (2010) 2.51
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 2.49
Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J (2008) 1.97
Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg (1998) 1.86
Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg (2003) 1.71
T4 lung tumors with infiltration of the thoracic aorta: is an operation reasonable? Ann Thorac Surg (1999) 1.70
Anomalous origin of the left coronary artery: a review of surgical management in 13 patients. J Cardiovasc Surg (Torino) (1993) 1.65
Hepatorenal reflex regulating kidney function. Hepatology (1991) 1.61
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J (2008) 1.58
Extracorporeal membrane oxygenation for graft failure after heart transplantation: recent Vienna experience. J Thorac Cardiovasc Surg (2001) 1.52
Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation (1996) 1.51
Rupture and dissection in pulmonary artery aneurysms: incidence, cause, and treatment--review and case report. J Thorac Cardiovasc Surg (2001) 1.49
Memantine for prevention of spinal cord injury in a rabbit model. J Thorac Cardiovasc Surg (1999) 1.49
Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg (1994) 1.42
Normothermic cardiopulmonary bypass is beneficial for cognitive brain function after coronary artery bypass grafting--a prospective randomized trial. Eur J Cardiothorac Surg (2000) 1.41
Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg (1989) 1.40
Neural drive to the diaphragm after lung volume reduction surgery. Chest (1999) 1.39
Valve-preserving treatment of Ebstein's anomaly: perioperative and follow-up results. Thorac Cardiovasc Surg (1999) 1.39
Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. Am J Transplant (2014) 1.39
Mesh tube-calibrated varicose veins for coronary artery bypass grafting. Ann Thorac Surg (1994) 1.38
Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest (2005) 1.38
Operations on the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe? J Thorac Cardiovasc Surg (1998) 1.38
Complete repair of PA-VSD with diminutive or discontinuous pulmonary arteries by transverse thoracosternotomy. Ann Thorac Surg (1996) 1.38
Leaflet fracture in Edwards-Duromedics bileaflet valves. J Thorac Cardiovasc Surg (1989) 1.30
Early postoperative stress: video-assisted wedge resection/lobectomy vs conventional axillary thoracotomy. Chest (1996) 1.24
Epicardial branches of the coronary arteries and their distribution in the rabbit heart: the rabbit heart as a model of regional ischemia. Anat Rec (1997) 1.20
Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs (2003) 1.17
Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost (1997) 1.16
Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg (2000) 1.13
Surgical treatment of type A aortic dissections. Results with profound hypothermia and circulatory arrest. Tex Heart Inst J (1995) 1.13
Central nervous system function after cardiopulmonary bypass. Eur Heart J (1993) 1.13
SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis. Thorax (2009) 1.10
Failure to detect IL-3-binding sites on human mast cells. J Immunol (1990) 1.10
Acute pulmonary trunk dissection in a patient with primary pulmonary hypertension. J Comput Assist Tomogr (2000) 1.09
Redo lung transplantation: a North American-European experience. J Heart Lung Transplant (1993) 1.08
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Histopathology (2004) 1.08
Accuracy of echocardiographic right ventricular parameters in patients with different end-stage lung diseases prior to lung transplantation. J Heart Lung Transplant (2000) 1.06
Prognostic factors in adenocarcinoma of the cardia. Am J Surg (1995) 1.05
Heightened levels of circulating 20S proteasome in critically ill patients. Eur J Clin Invest (2005) 1.05
Buttressing the staple line in lung volume reduction surgery: a randomized three-center study. Ann Thorac Surg (2000) 1.04
Impact of different coverage techniques on incidence of postpneumonectomy stump fistula. Eur J Cardiothorac Surg (1999) 1.04
Clinical ex vivo lung perfusion--pushing the limits. Am J Transplant (2012) 1.04
The effects of thoracic epidural analgesia with bupivacaine 0.25% on ventilatory mechanics in patients with severe chronic obstructive pulmonary disease. Anesth Analg (2001) 1.04
Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant (2007) 1.04
First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation (2000) 1.03
T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease. Clin Exp Immunol (2009) 1.03
Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Thorac Cardiovasc Surg (2006) 1.01
Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant (2000) 1.00
[Effect of hexabendin on oxygen consumption, energetics and substrate metabolism of the heart. II. Studies with intravenously administered single doses]. Arzneimittelforschung (1966) 0.99
Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro. Br J Dermatol (2008) 0.99
Pulmonary alveolar microlithiasis: findings on high-resolution CT. AJR Am J Roentgenol (1992) 0.98
Implantation of the Duromedics bileaflet cardiac valve prosthesis in 400 patients. Ann Thorac Surg (1987) 0.96
Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection. Transplantation (2001) 0.93
Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells. Immunol Lett (1993) 0.93
Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol (1999) 0.92
Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension. J Heart Lung Transplant (1999) 0.92
Five-year follow-up after heart valve replacement with the CarboMedics bileaflet prosthesis. Ann Thorac Surg (1997) 0.92
Functional improvement after volume reduction: sternotomy versus videoendoscopic approach. Ann Thorac Surg (1997) 0.91
[The local application of fibrinogen and collagen for hemostasis in heart surgery]. Wien Med Wochenschr (1976) 0.91
Impact of systemic immuno-suppression after solid organ transplantation on allergen-specific responses. Allergy (2010) 0.90
Development of the Baylor Gyro permanently implantable centrifugal blood pump as a biventricular assist device. Artif Organs (2001) 0.90
No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH) Thromb Haemost (1996) 0.89
Independent prognostic role of p16 expression in lung cancer. J Thorac Cardiovasc Surg (1999) 0.89
Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost (2007) 0.89
Differential expression of cell surface integrins on human mast cells and human basophils. Ann Hematol (1992) 0.89
Elevated levels of interleukin-1beta-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction. Eur J Clin Invest (2007) 0.89
Four year follow-up of the Duromedics Edwards bileaflet valve prostheses. J Cardiovasc Surg (Torino) (1990) 0.89
Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting. Ann Thorac Surg (2001) 0.89
Endovascular stent graft repair for aneurysms on the descending thoracic aorta. Ann Thorac Surg (1998) 0.88
Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry. Ann Thorac Surg (1998) 0.88
Pulmonary and aortic blood flow measurements in normal subjects and patients after single lung transplantation at 0.5 T using velocity encoded cine MRI. Chest (1998) 0.88
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol (2014) 0.88
Metal ion-induced toxic histamine release from human basophils and mast cells. J Biomed Mater Res (1998) 0.88
Thoracic aortic aneurysms: treatment with endovascular self-expandable stent grafts. Ann Thorac Surg (2000) 0.87
Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Clin Exp Immunol (2001) 0.87
Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation (2001) 0.87
IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease. Clin Exp Immunol (1999) 0.87
[Fibrin sealing in surgery (author's transl)]. Wien Klin Wochenschr (1982) 0.87
Analysis of cell cycle regulator proteins in non-small cell lung cancer. J Clin Pathol (2004) 0.87
Results of open heart surgery in Jehovah's Witnesses patients. J Cardiovasc Surg (Torino) (2009) 0.87
The pulmonary nodule after lung transplantation. Cause and outcome. Chest (1995) 0.87
Plaque ablation by excimer laser irradiation using a movable energy-transmitting device. Tex Heart Inst J (1987) 0.86
Emergency aortic valve replacement for critical aortic stenosis. A lifesaving treatment for patients with cardiogenic shock and multiple organ failure. Intensive Care Med (1997) 0.86